Aurobindo Pharma rises on plans to expand its footprints in EU countries

03 Jul 2017 Evaluate

Aurobindo Pharma is currently trading at Rs. 685.75, up by 2.30 points or 0.34% from its previous closing of Rs. 683.45 on the BSE.

The scrip opened at Rs. 685.60 and has touched a high and low of Rs. 690.00 and Rs. 679.75 respectively. So far 1,30,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 895.00 on 06-Oct-2016 and a 52 week low of Rs. 504.00 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 692.50 and Rs. 658.55 respectively. The current market cap of the company is Rs. 40,179.00 crore.

The promoters holding in the company stood at 51.87%, while Institutions and Non-Institutions held 33.75% and 14.38% respectively.

Aurobindo Pharma is planning to expand into European Union (EU) countries such as Poland and the Czech Republic as part of its broader efforts to consolidate business over the next 3-4 years. The company, which is also eyeing growth in Italy and Spain, is planning to launch various new products in the US market.

Moreover, the Hyderabad-based firm is working on plans to launch cancer treatment and injectable products in the European Union. The acquisition of Generis Farmaceutica SA has already catapulted the company into a big league in the Portuguese generic market in terms of value and volume. It has also completed the acquisition of Orocal brand to leverage its position as a key player in the French drug market.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1089.45 19.45 (1.82%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.